UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2003
OR
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ______ to ________
Commission File Number: 0-50194
HMS HOLDINGS CORP.
New York (State or other jurisdiction of incorporation or organization) |
11-3656261 (I.R.S. Employer Identification No.) |
|
401 Park Avenue South, New York, New York (Address of principal executive offices) |
10016 (Zip Code) |
(212) 725-7965
(Registrants telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes [ ] No [X]
The number of shares of common stock, $.01 par value, outstanding as of November 4, 2003 was 18,373,922.
HMS HOLDINGS CORP. AND SUBSIDIARIES
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
Page | ||||||||
PART I - FINANCIAL INFORMATION | ||||||||
Item 1. | Financial Statements |
|||||||
Condensed Consolidated Balance Sheets (unaudited) as of September 30, 2003 and
December 31, 2002 |
3 | |||||||
Condensed Consolidated Statements of Operations (unaudited) for the three months and
nine months ended September 30, 2003 and 2002 |
4 | |||||||
Condensed Consolidated Statement of Shareholders Equity and Comprehensive
Loss (unaudited) for the nine months ended September 30, 2003 |
5 | |||||||
Condensed Consolidated Statements of Cash Flows (unaudited) for the nine months
ended September 30, 2003 and 2002 |
6 | |||||||
Notes to Condensed Consolidated Financial Statements (unaudited) |
7 | |||||||
Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
13 | ||||||
Item 3. | Quantitative and Qualitative Disclosures About Market Risks |
19 | ||||||
Item 4. | Controls and Procedures |
20 | ||||||
PART II - OTHER INFORMATION | ||||||||
Item 1. | Legal Proceedings |
20 | ||||||
Item 6. | Exhibits and Reports on Form 8-K |
21 | ||||||
Signatures | 23 |
2
HMS HOLDINGS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
(unaudited)
September 30, | December 31, | ||||||||||
2003 | 2002 | ||||||||||
Assets |
|||||||||||
Current assets: |
|||||||||||
Cash and cash equivalents |
$ | 24,600 | $ | 24,174 | |||||||
Short-term investments |
100 | 1,108 | |||||||||
Accounts receivable, net |
16,004 | 15,312 | |||||||||
Prepaid expenses and other current assets |
1,434 | 1,207 | |||||||||
Total current assets |
42,138 | 41,801 | |||||||||
Property and equipment, net |
3,491 | 4,912 | |||||||||
Goodwill |
5,679 | 5,679 | |||||||||
Deferred income taxes, net |
8,920 | 8,920 | |||||||||
Other assets |
200 | 354 | |||||||||
Total assets |
$ | 60,428 | $ | 61,666 | |||||||
Liabilities and Shareholders Equity |
|||||||||||
Current liabilities: |
|||||||||||
Accounts payable, accrued expenses and other liabilities |
$ | 11,498 | $ | 13,176 | |||||||
Total current liabilities |
11,498 | 13,176 | |||||||||
Other liabilities |
748 | 722 | |||||||||
Total liabilities |
12,246 | 13,898 | |||||||||
Commitments and contingencies |
|||||||||||
Shareholders equity: |
|||||||||||
Preferred stock - $.01 par value; 5,000,000 shares authorized; none issued |
| ||||||||||
Common stock - $.01 par value; 45,000,000 shares authorized; |
|||||||||||
20,018,838
shares issued and 18,373,922 shares outstanding at September 30,
2003;
19,885,390 shares issued and 18,276,274 shares outstanding at December 31, 2002; |
200 | 199 | |||||||||
Capital in excess of par value |
75,125 | 74,959 | |||||||||
Unearned stock compensation |
(3 | ) | (33 | ) | |||||||
Accumulated deficit |
(17,851 | ) | (17,820 | ) | |||||||
Accumulated other comprehensive income |
| 8 | |||||||||
Treasury
stock, at cost; 1,644,916 shares at September 30, 2003 and
1,609,116 shares at
December 31, 2002 |
(9,289 | ) | (9,184 | ) | |||||||
Note receivable from officer for sale of stock |
| (361 | ) | ||||||||
Total shareholders equity |
48,182 | 47,768 | |||||||||
Total liabilities and shareholders equity |
$ | 60,428 | $ | 61,666 | |||||||
See accompanying notes to condensed consolidated financial statements.
3
HMS HOLDINGS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)
Three months ended | Nine months ended | ||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||
2003 | 2002 | 2003 | 2002 | ||||||||||||||||
Revenue |
$ | 18,708 | $ | 17,024 | $ | 53,482 | $ | 50,638 | |||||||||||
Cost of services: |
|||||||||||||||||||
Compensation |
9,608 | 9,275 | 29,097 | 28,191 | |||||||||||||||
Data processing |
1,180 | 1,154 | 3,557 | 4,879 | |||||||||||||||
Occupancy |
1,375 | 1,533 | 4,227 | 4,597 | |||||||||||||||
Direct project costs |
3,286 | 2,666 | 9,580 | 7,358 | |||||||||||||||
Other operating costs |
2,251 | 2,192 | 7,466 | 8,176 | |||||||||||||||
Total cost of services |
17,700 | 16,820 | 53,927 | 53,201 | |||||||||||||||
Operating income (loss) |
1,008 | 204 | (445 | ) | (2,563 | ) | |||||||||||||
Net interest income |
46 | 124 | 202 | 413 | |||||||||||||||
Income (loss) from continuing operations before income taxes |
1,054 | 328 | (243 | ) | (2,150 | ) | |||||||||||||
Income tax expense (benefit) |
| | | | |||||||||||||||
Income (loss) from continuing operations |
1,054 | 328 | (243 | ) | (2,150 | ) | |||||||||||||
Income from discontinued operations, net |
212 | | 212 | 2,900 | |||||||||||||||
Net income (loss) |
$ | 1,266 | $ | 328 | $ | (31 | ) | $ | 750 | ||||||||||
Basic earnings per share data: |
|||||||||||||||||||
Income (loss) per share from continuing operations |
$ | 0.06 | $ | 0.02 | $ | (0.01 | ) | $ | (0.12 | ) | |||||||||
Income per share from discontinued operations, net |
0.01 | | 0.01 | 0.16 | |||||||||||||||
Net income (loss) per share |
$ | 0.07 | $ | 0.02 | $ | | $ | 0.04 | |||||||||||
Diluted earnings per share data: |
|||||||||||||||||||
Income (loss) per share from continuing operations |
$ | 0.05 | $ | 0.02 | $ | (0.01 | ) | $ | (0.12 | ) | |||||||||
Income per share from discontinued operations, net |
0.01 | | 0.01 | 0.16 | |||||||||||||||
Net income (loss) per share |
$ | 0.06 | $ | 0.02 | $ | | $ | 0.04 | |||||||||||
Weighted average common shares outstanding: |
|||||||||||||||||||
Basic |
18,369 | 18,259 | 18,310 | 18,188 | |||||||||||||||
Diluted |
20,286 | 20,001 | 18,310 | 18,188 | |||||||||||||||
See accompanying notes to condensed consolidated financial statements.
4
HMS HOLDINGS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY AND COMPREHENSIVE LOSS
For the Nine Months Ended September 30, 2003
(in thousands, except share amounts)
(unaudited)
Common Stock | Accumulated | Note | |||||||||||||||||||||||||||||||||||||||
Capital In | Unearned | Other | Treasury Stock | Receivable | Total | ||||||||||||||||||||||||||||||||||||
# of Shares | Par | Excess Of | Stock | Accumulated | Comprehensive | from Sale | Shareholders | ||||||||||||||||||||||||||||||||||
Issued | Value | Par Value | Compensation | Deficit | Income (Loss) | # of Shares | Amount | of Stock | Equity | ||||||||||||||||||||||||||||||||
Balance at December 31, 2002 |
19,885,390 | $ | 199 | $ | 74,959 | $ | (33 | ) | $ | (17,820 | ) | $ | 8 | 1,609,116 | $ | (9,184 | ) | $ | (361 | ) | $ | 47,768 | |||||||||||||||||||
Comprehensive loss: |
|||||||||||||||||||||||||||||||||||||||||
Net loss |
| | | | (31 | ) | | | | | (31 | ) | |||||||||||||||||||||||||||||
Change in net unrealized
appreciation on
short-term investments |
| | | | | (8 | ) | | | | (8 | ) | |||||||||||||||||||||||||||||
Total comprehensive loss |
(39 | ) | |||||||||||||||||||||||||||||||||||||||
Repayment of note receivable |
| | | | | | | | 361 | 361 | |||||||||||||||||||||||||||||||
Shares issued under employee
stock purchase plan |
17,380 | | 48 | | | | | | | 48 | |||||||||||||||||||||||||||||||
Exercise of stock options |
116,068 | 1 | 149 | | | | | | | 150 | |||||||||||||||||||||||||||||||
Purchase of treasury stock |
| | | | | | 35,800 | (105 | ) | | (105 | ) | |||||||||||||||||||||||||||||
Remeasurement of unearned
stock compensation |
| | (31 | ) | 31 | | | | | | | ||||||||||||||||||||||||||||||
Stock compensation (credit) |
| | | (1 | ) | | | | | | (1 | ) | |||||||||||||||||||||||||||||
Balance at September 30, 2003 |
20,018,838 | $ | 200 | $ | 75,125 | $ | (3 | ) | $ | (17,851 | ) | $ | | 1,644,916 | $ | (9,289 | ) | $ | | $ | 48,182 | ||||||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
5
HMS HOLDINGS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended September 30, 2003 and 2002
(in thousands)
(unaudited)
2003 | 2002 | |||||||||||
Operating activities: |
||||||||||||
Net income (loss) |
$ | (31 | ) | $ | 750 | |||||||
Adjustments to reconcile net income (loss) to net cash
used in operating activities: |
||||||||||||
Income from discontinued operations |
(212 | ) | (2,900 | ) | ||||||||
Loss on disposal/impairment of property and equipment |
25 | 612 | ||||||||||
Depreciation and amortization |
1,991 | 1,812 | ||||||||||
Provision for doubtful accounts |
225 | 231 | ||||||||||
Stock compensation expense (credit) |
(1 | ) | 649 | |||||||||
Changes in assets and liabilities: |
||||||||||||
Increase in accounts receivable |
(917 | ) | (4,276 | ) | ||||||||
(Increase) decrease in prepaid expenses and other current assets |
(207 | ) | 992 | |||||||||
Decrease in other assets |
154 | 357 | ||||||||||
Decrease in accounts payable, accrued expenses
and other liabilities |
(1,652 | ) | (1,230 | ) | ||||||||
Net cash used in operating activities |
(625 | ) | (3,003 | ) | ||||||||
Investing activities: |
||||||||||||
Purchases of property and equipment |
(595 | ) | (2,671 | ) | ||||||||
Net proceeds from sales of short-term investments |
1,000 | 1,234 | ||||||||||
Net cash provided by (used in) investing activities |
405 | (1,437 | ) | |||||||||
Financing activities: |
||||||||||||
Proceeds from exercise of stock options |
150 | 581 | ||||||||||
Repayment of note receivable from officer for purchase of common stock |
361 | 361 | ||||||||||
Purchases of treasury stock |
(105 | ) | (869 | ) | ||||||||
Proceeds from issuance of common stock |
48 | 90 | ||||||||||
Net cash provided by financing activities |
454 | 163 | ||||||||||
Net increase (decrease) in cash and cash equivalents |
234 | (4,277 | ) | |||||||||
Cash and cash equivalents at beginning of period |
24,174 | 21,020 | ||||||||||
Cash provided by discontinued operations |
192 | 2,996 | ||||||||||
Cash and cash equivalents at end of period |
$ | 24,600 | $ | 19,739 | ||||||||
Supplemental disclosure of non-cash investing and financing activities: |
||||||||||||
Change in unearned compensation |
$ | 31 | $ | 48 | ||||||||
Supplemental disclosure of cash flow information: |
||||||||||||
Cash paid for income taxes |
$ | 18 | $ | 138 | ||||||||
See accompanying notes to condensed consolidated financial statements.
6
HMS HOLDINGS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. | Unaudited Interim Financial Information |
The management of HMS Holdings Corp. (the Company) is responsible for the accompanying unaudited interim condensed consolidated financial statements and the related information included in the notes to the condensed consolidated financial statements. In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments, including normal recurring adjustments necessary for the fair presentation of the Companys financial position and results of operations and cash flows for the periods presented. Results of operations for interim periods are not necessarily indicative of the results to be expected for the entire year.
These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company as of and for the year ended December 31, 2002 included in the Companys Annual Report on Form 10-K for such year, as filed with the Securities and Exchange Commission (the SEC).
2. | Stock-Based Compensation |
The Company accounts for stock-based compensation under Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation. As permitted by SFAS No. 123, the Company has elected to continue following the provisions of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and to adopt only the disclosure provision of SFAS No. 123. Accordingly, no employee compensation costs have been recognized for its stock purchase plan and stock option plans. Had compensation costs for the Companys stock options been determined consistent with the fair value method prescribed by SFAS 123, the Companys net income (loss) and related per share amounts would have been adjusted to the pro forma amounts indicated below:
7
HMS HOLDINGS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
(in thousands, except per share amounts) | 2003 | 2002 | 2003 | 2002 | |||||||||||||
Net income (loss), as reported |
$ | 1,266 | $ | 328 | $ | (31 | ) | $ | 750 | ||||||||
Stock-based employee compensation expense
included in reported net income (loss) |
| | | | |||||||||||||
Total stock-based employee compensation
expense determined under fair value
based method for all awards, net of
related tax effects |
(484 | ) | (352 | ) | (1,425 | ) | (1,234 | ) | |||||||||
Pro forma net income (loss) |
$ | 782 | $ | (24 | ) | $ | (1,456 | ) | $ | (484 | ) | ||||||
Net income (loss) per basic
share |
|||||||||||||||||
As reported |
$ | 0.07 | $ | 0.02 | $ | | $ | 0.04 | |||||||||
Pro forma |
$ | 0.04 | $ | | $ | (0.08 | ) | $ | (0.03 | ) | |||||||
Net income (loss) per diluted
share |
|||||||||||||||||
As reported |
$ | 0.06 | $ | 0.02 | $ | | $ | 0.04 | |||||||||
Pro forma |
$ | 0.04 | $ | | $ | (0.08 | ) | $ | (0.03 | ) |
The effect presented above by applying the disclosure-only provisions of SFAS 123 may not be representative of the pro forma effect in future years.
At the Annual Meeting of Shareholders on June 4, 2003, the shareholders approved an amendment to the 1999 Long-Term Incentive Stock Plan to increase the number of shares of common stock available for issuance under the plan from 4,751,356 shares to 6,251,356 shares.
3. | Basis of Presentation and Principles of Consolidation |
(a) Organization and Business
At a special meeting held on February 27, 2003, the shareholders of Health Management Systems, Inc. approved the creation of a holding company structure. Following that meeting, all the outstanding shares of Health Management Systems, Inc. common stock were exchanged on a one-for-one basis for the shares of common stock of HMS Holdings Corp., the new parent company. The adoption of the holding company structure, pursuant to an Agreement and Plan of Merger approved at the shareholders meeting, constituted a reorganization with no change in ownership interests or accounting basis and no dilutive impact to the former shareholders of Health Management Systems, Inc.
The Company furnishes revenue recovery, business process and business office outsourcing services to healthcare payors and providers. The Company helps clients increase revenue, accelerate collections, and reduce operating and administrative costs. The Company operates two businesses through its wholly-owned subsidiaries, Health Management Systems, Inc. (formerly the Payor Services Division) and Accordis Inc. (formerly the Provider Services Division).
(b) Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
8
HMS HOLDINGS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
(c) Discontinued Operations of Business Segment
During the year ended December 31, 2001, the Company implemented a formal plan to proceed with an orderly closure of the Payor Systems Group (PSG) business unit. In prior periods, PSG had been a separate reportable segment. The current and historical operating results of PSG have been reported as discontinued operations on the accompanying Condensed Consolidated Statements of Operations.
(d) Reclassifications
Certain reclassifications were made to prior period amounts to conform to the current period presentation.
4. | Income Taxes |
For the nine months ended September 30, 2003, the Company generated additional gross deferred tax assets of $12,000 resulting from the Companys net operating loss of $31,000. Correspondingly, the Company recognized an increase in the valuation allowance related to the realizability of its deferred tax assets in the amount of $12,000 for the nine month period ended September 30, 2003. As the Company generated net income for the three months ended September 30, 2003, during the quarter ended September 30, 2003, the Company reduced both the previously recorded gross deferred taxes and valuation allowance by $508,000. The net deferred tax asset balance was therefore $8.9 million at both September 30, 2003 and December 31, 2002. The year to date increase in the valuation allowance was specifically associated with the Companys net operating loss carryforwards (NOLs), which account for the majority of the Companys deferred tax assets. The Company believes the available objective evidence, principally its recent taxable losses, creates sufficient uncertainty regarding the realizability of its NOLs that it is more likely than not that some of the NOLs are not realizable. The Company determined the amount of the valuation allowance based on its assessment of the recoverability of the deferred tax assets by projecting future taxable income. The realizability of the Companys deferred tax assets and the corresponding valuation allowance will be adjusted in the future based on the Companys actual taxable income results and updated estimates of future taxable income. The Company believes that it is more likely than not that the results of future operations will generate sufficient taxable income to realize the deferred tax assets, net of valuation allowance, based on its projection of future operating results.
5. | Earnings Per Share |
Basic earnings per share is calculated as net income divided by the weighted average common shares outstanding. Diluted earnings per share is calculated as net income divided by the weighted average common shares outstanding including the dilutive effects of potential common shares, which include the Companys stock options. For the three months ended September 30, 2003 and 2002, the common stock equivalents are included in the weighted average shares. The diluted weighted average number of shares outstanding for the three months ended September 30, 2003 and 2002 were 20,285,905 and 20,000,796, respectively. The diluted weighted average number of shares outstanding for the nine months ended September 30, 2003 and 2002 were 19,869,618 and 20,488,345, respectively, and have been excluded from the weighted average shares as it would be antidilutive to the per share calculation.
9
HMS HOLDINGS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
6. | Discontinued Operations |
On July 31, 2001, the Company implemented a formal plan to proceed with an orderly closing of PSG. As of July 31, 2001, the Company estimated a pre-tax loss on disposal of $1.6 million but as a result of its success in exiting various business obligations, the Company reduced its estimated loss to $200,000 as of December 31, 2001. In the quarter ended June 30, 2002, the Company received a $2.7 million contract termination fee, which was not included in the disposal estimate. In addition, during the quarter ended June 30, 2002, the Company reduced the estimated loss on disposal by $200,000, based on actual operating results through that period. Consequently, the Company recognized income from discontinued operations, in the accompanying condensed consolidated financial statements, of $2.9 million during the nine month period ended September 30, 2002. During the three months ended September 30, 2003, the Company recorded $212,000 of income based on actual operating results during that period.
7. | Commitments Legal Proceedings |
(a) HHL Financial Services
On June 28, 1998, eight holders of promissory notes (the Notes) of HHL Financial Services, Inc. (HHL) commenced a lawsuit against the Company and others in the Supreme Court of the State of New York, County of Nassau, alleging various breaches of fiduciary duty between 1990 and 1996 against HHL (the first cause of action) and that defendants intentionally caused HHLs default under the Notes (the second cause of action). The complaint alleges that the defendants caused HHL to make substantial unjustified payments to the Company which, ultimately, led to defaults on the Notes and to HHLs filing for Chapter 11 bankruptcy protection in 1997. The plaintiffs are seeking damages in the amount of $2.3 million (for the unpaid notes) plus interest. As a result of motion practice before the Bankruptcy Court, the breach of fiduciary duty claim was dismissed. A motion to dismiss the remaining cause of action, for tortious interference with contract, was denied by the New York Supreme Court, and an appeal was taken. On March 3, 2003, the Appellate Division Second Department affirmed the lower Courts decision holding that the Complaint pleaded a cognizable cause of action for tortious interference. The Company has answered the Complaint, and both sides are engaging in discovery. The Company intends to continue its vigorous defense of this lawsuit. Management believes the risk of loss is not probable and accordingly has not recognized any accrued liability for this matter. Although the outcome of this matter cannot be predicted with certainty, the Company believes that any liability that may result will not, in the aggregate, have a material adverse effect on the Companys financial position or cash flows, although it could be material to its operating results in any one accounting period.
(b) Subpoena from the United States Attorneys Office
On January 31, 2003, the Company announced that it had received a subpoena issued under the Health Insurance Portability and Accountability Act of 1996 from the United States Attorneys Office for the Southern District of New York in connection with an investigation relating to possible federal health care offenses. The subpoena seeks the production of certain documents from January 1982 to present relating to medical reimbursement claims submitted by the Company to Medicare, Medicaid, and other federal healthcare programs, particularly on behalf of a significant client of Accordis. At this point in the investigation, the United States Attorneys Office has not filed any complaint asserting any violations of law.
The Companys board of directors has appointed a special committee to oversee the Companys response to the investigation. The Company continues to cooperate fully with the investigation.
10
HMS HOLDINGS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
The Company is not able to give any assurances as to the duration or outcome of the investigation or as to the effect that any proceedings that may be brought by the government may have on the Companys financial condition or results of operations. The initiation of proceedings against the Company, even if the Company is ultimately successful in defending itself, could have a material adverse effect on the Companys business. Since the receipt of the subpoena, the Companys revenue and expense levels have been adversely affected as management undertook to comply with the demands of document production and to review the matters covered by the subpoena. The Company anticipates that it will continue to incur significant legal expenses while the investigation is still ongoing.
Other legal proceedings to which the Company is a party, in the opinion of the Companys management, are not expected to have a material adverse effect on the Companys financial position, results of operations, or liquidity.
8. | Segment Information |
Accordis offers hospitals and other healthcare providers a comprehensive array of technology-based revenue cycle services. These services include identifying third-party resources, submitting timely and accurate bills to third-party payors and patients, recovering and properly accounting for the amounts due, and securing the appropriate cost-based reimbursement from entitlement programs. Clients may use one or more services, or outsource the entirety of their business office operations to the Company. Health Management Systems offers state Medicaid and other government agencies that administer healthcare entitlement programs a broad range of services that are designed to identify and recover amounts that should have been the responsibility of a third party, or that were paid inappropriately. Further, by assisting these agencies in properly accounting for the services that they deliver, the Company also helps to ensure that they receive the full amount of entitlement program funding to which they are entitled. The Company measures the performance of its operating segments through Operating Income as defined in the accompanying Condensed Consolidated Statements of Operations.
11
HMS HOLDINGS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
Total | Health | ||||||||||||||||
HMS | Management | ||||||||||||||||
(in thousands) | Holdings | Accordis | Systems | Corporate | |||||||||||||
As of and for the three months ended September 30, 2003 |
|||||||||||||||||
Revenue |
$ | 18,708 | $ | 9,860 | $ | 8,848 | $ | | |||||||||
Operating income (loss) |
1,008 | (275 | ) | 1,283 | | ||||||||||||
Total assets |
60,428 | 16,157 | 10,651 | 33,620 | |||||||||||||
Goodwill |
5,679 | 4,596 | 1,083 | | |||||||||||||
Depreciation and amortization |
614 | 350 | 264 | | |||||||||||||
Capital expenditures |
284 | 102 | 182 | | |||||||||||||
As of and for the three months ended September 30, 2002 |
|||||||||||||||||
Revenue |
$ | 17,024 | $ | 9,424 | $ | 7,600 | $ | | |||||||||
Operating income (loss) |
204 | (923 | ) | 1,127 | | ||||||||||||
Total assets |
60,621 | 18,763 | 10,343 | 31,515 | |||||||||||||
Goodwill |
5,679 | 4,596 | 1,083 | | |||||||||||||
Depreciation and amortization |
622 | 326 | 296 | | |||||||||||||
Capital expenditures |
1,717 | 868 | 849 | | |||||||||||||
As of and for the nine months ended September 30, 2003 |
|||||||||||||||||
Revenue |
$ | 53,482 | $ | 26,695 | $ | 26,787 | $ | | |||||||||
Operating income (loss) |
(445 | ) | (4,991 | ) | 4,546 | | |||||||||||
Total assets |
60,428 | 16,157 | 10,651 | 33,620 | |||||||||||||
Goodwill |
5,679 | 4,596 | 1,083 | | |||||||||||||
Depreciation and amortization |
1,991 | 1,043 | 948 | | |||||||||||||
Capital expenditures |
595 | 235 | 360 | | |||||||||||||
As of and for the nine months ended September 30, 2002 |
|||||||||||||||||
Revenue |
$ | 50,638 | $ | 26,692 | $ | 23,946 | $ | | |||||||||
Operating income (loss) |
(2,563 | ) | (6,355 | ) | 3,792 | | |||||||||||
Total assets |
60,621 | 18,763 | 10,343 | 31,515 | |||||||||||||
Goodwill |
5,679 | 4,596 | 1,083 | | |||||||||||||
Depreciation and amortization |
1,812 | 954 | 858 | | |||||||||||||
Capital expenditures |
2,671 | 1,374 | 1,297 | | |||||||||||||
Assets, including prepaid expenses, property and equipment and goodwill have been allocated to identified segments based upon actual usage, occupancy or other correlations with operating metrics. Other corporate assets, including cash, short-term investments and deferred tax assets, are shown in the corporate category. Prior years amounts include reclassifications to conform with the Companys current methodology.
9. | Impact of Recently Issued Accounting Standards |
In June 2002, the Financial Accounting Standards Board issued Statement No. 146, Accounting for Costs Associated with Exit or Disposal Activities (SFAS 146). SFAS 146 supercedes Emerging Issues Task Force Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring) and requires that a liability for the cost associated with an exit or disposal activity be recognized when the liability is incurred, as opposed to the date of an entitys commitment to an exit plan. The provisions of SFAS 146 are effective for exit or disposal activities that are initiated after December 31, 2002. SFAS 146 will affect the types and timing of costs included in future restructuring programs, if any.
12
Special Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. For this purpose any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements. These statements involve unknown risks, uncertainties and other factors, which may cause our actual results to differ materially from those implied by the forward looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are those risks identified in Item 7 Managements Discussion and Analysis of Financial Condition and Results of Operations and other risks identified in our Form 10-K for the year ended December 31, 2002 and presented elsewhere by management from time to time. Such forward-looking statements represent managements current expectations and are inherently uncertain. Investors are warned that actual results may differ from managements expectations.
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Critical Accounting Policies
For information regarding our critical accounting policies, please refer to our Annual Report on Form 10-K for the year ended December 31, 2002.
Three Months Ended September 30, 2003 Compared to Three Months Ended September 30, 2002
The following table sets forth, for the periods indicated, certain items in our Condensed Consolidated Statements of Operations expressed as a percentage of revenue:
Three Months Ended September 30, | |||||||||
2003 | 2002 | ||||||||
Revenue |
100.0 | % | 100.0 | % | |||||
Cost of services: |
|||||||||
Compensation |
51.4 | % | 54.4 | % | |||||
Data processing |
6.3 | % | 6.8 | % | |||||
Occupancy |
7.3 | % | 9.0 | % | |||||
Direct project costs |
17.6 | % | 15.7 | % | |||||
Other operating costs |
12.0 | % | 12.9 | % | |||||
Total cost of services |
94.6 | % | 98.8 | % | |||||
Operating income |
5.4 | % | 1.2 | % | |||||
Net interest income |
0.2 | % | 0.7 | % | |||||
Income from continuing operations before income taxes |
5.6 | % | 1.9 | % | |||||
Income tax benefit |
| | |||||||
Income from continuing operations |
5.6 | % | 1.9 | % | |||||
Income from discontinued operations, net |
1.2 | % | | ||||||
Net income |
6.8 | % | 1.9 | % | |||||
13
Revenue for the quarter ended September 30, 2003 was $18.7 million, an increase of $1.7 million or 9.9% compared to revenue of $17.0 million in the prior year quarter ended September 30, 2002.
Health Management Systems, which provides third party liability identification and recovery services to state Medicaid agencies, generated revenue of $8.8 million for the three months ended September 30, 2003, a $1.2 million or 16.4% increase over revenue for the three months ended September 30, 2002 of $7.6 million. This increase primarily reflects a $162,000 increase in revenue from two state customers resulting from an expansion in the scope of services provided and a $1.1 million increase across the comparable client base reflecting non-recurring revenue opportunities, timing differences and changes in the volume, yields and scope of client projects.
Accordis, which provides outsourced business office services for hospitals, generated revenue of $9.9 million for the three months ended September 30, 2003, an increase of $438,000 from $9.4 million for the three months ended September 30, 2002. This increase includes $1.2 million of revenue from three new customers and a $688,000 increase with four customers resulting from an expansion in the scope of services provided. Revenue decreased by $740,000 across the comparable client base reflecting specific non-recurring revenue opportunities with certain clients based on their particular needs, differences in the timing of when client projects were completed in the current year compared with the prior year, and changes in the volume and yields of client projects. There was also a decrease in revenue of $699,000 associated with nine terminated or inactive customer relationships.
Compensation expense as a percentage of revenue was 51.4% for the three months ended September 30, 2003 compared to 54.4% for the three months ended September 30, 2002 and for the current quarter was $9.6 million, an increase of $333,000, or 3.6% from the prior year quarter expense of $9.3 million. This increase in expense resulted from an increase in headcount from the comparable prior year period, a general increase in compensation rates and increased costs of fringe benefits. At September 30, 2003, we had 494 employees, compared to 480 employees at September 30, 2002.
Data processing expense as a percentage of revenue was 6.3% for the three months ended September 30, 2003 compared to 6.8% for the three months ended September 30, 2002 and for the current quarter was $1.2 million, which was consistent with the prior year quarter expense.
Occupancy expense as a percentage of revenue was 7.3% for the three months ended September 30, 2003 compared to 9.0% for the three months ended September 30, 2002 and for the current quarter was $1.4 million, a decrease of $158,000 or 10.3% from the prior year quarter expense of $1.5 million. The reduction in occupancy costs is due to subletting one floor at our New York City headquarters in 2003.
In fiscal years 2002 and 2001, direct project costs as a percentage of revenue were approximately 15% to 16%. The Company has experienced quarterly variations of as much as 2% in that percentage range based on the particular mix of client business in the period. In fiscal year 2003 the Company has attempted to more precisely identify as direct project costs, expenses that were previously classified as other operating costs. As a consequence, the Company expects that in fiscal 2003 direct project costs as a percentage of revenue will be approximately 17% to 18%, subject to quarterly variations comparable to past experience.
Direct project costs as a percentage of revenue were 17.6% for the three months ended September 30, 2003 compared to 15.7% for the three months ended September 30, 2002 and for the current quarter were $3.3 million, an increase of $620,000 or 23.3% from the prior year quarter expense of $2.7 million. In addition to the discussion above, during the current quarter, the increases related to Accordis and Health Management Systems were consistent with the increases in revenue.
14
Other operating costs as a percentage of revenue were 12.0% for the three months ended September 30, 2003 compared to 12.9% for the three months ended September 30, 2002 and for the current quarter were $2.3 million, an increase of $59,000 or 2.7% compared to the prior year quarter expense of $2.2 million. This increase reflects $300,000 in expenses during the current period primarily for legal fees associated with our response to the subpoena from the United States Attorneys office and was partially offset by the more strict identification of some expenses as direct project costs, as discussed above.
Operating income for the three months ended September 30, 2003 was $1.0 million compared to $204,000 for the three months ended September 30, 2002. The Accordis operating loss was $275,000 for the quarter ended September 30, 2003 compared to an operating loss of $923,000 in the prior year quarter. Health Management Systems had an operating profit of $1.3 million for the quarter ended September 30, 2003 compared to an operating profit of $1.1 million for the quarter ended September 30, 2002. The Accordis operating loss in the current year quarter includes $300,000 for legal fees associated with our response to the subpoena from the United States Attorneys Office.
Net interest income of $46,000 for the three months ended September 30, 2003, compared with $124,000 for the three months ended September 30, 2002, reflects a shift to shorter-term investments, a reduction in market interest rates and the maturing of certain investments with higher rates of return.
In 2003 and 2002, we did not recognize any income tax benefit or provision. We have incurred significant taxable losses the last several years. Most of our deferred income tax assets are in the form of net operating loss carryforwards. A recoverability analysis was performed based on our recent taxable loss history and projections of future taxable operating results.
Income from continuing operations was $1.1 million in the current year three-month period compared to $328,000 during the prior year period. This increase in operating income results from the increased revenues and from the reductions in costs of operations as a percentage of revenues, as discussed above.
Income from discontinued operations was $212,000 or $0.01 per diluted common share in the current year quarter due to the actual operating result of PSG during the wind-down of their business.
Net income was $1.3 million or $0.06 per diluted common share in the current year quarter compared with $328,000 or $0.02 per diluted common share in the prior year quarter. This increase in income is principally due to the increased revenues and from the reductions in costs of operations as a percentage of revenues, as discussed above.
Nine Months Ended September 30, 2003 Compared to Nine Months Ended September 30, 2002
The following table sets forth, for the periods indicated, certain items in our Condensed Consolidated Statements of Operations expressed as a percentage of revenue:
15
Nine Months Ended September 30, | |||||||||
2003 | 2002 | ||||||||
Revenue |
100.0 | % | 100.0 | % | |||||
Cost of services: |
|||||||||
Compensation |
54.3 | % | 55.8 | % | |||||
Data processing |
6.7 | % | 9.6 | % | |||||
Occupancy |
7.9 | % | 9.1 | % | |||||
Direct project costs |
17.9 | % | 14.5 | % | |||||
Other operating costs |
14.0 | % | 16.1 | % | |||||
Total cost of services |
100.8 | % | 105.1 | % | |||||
Operating loss |
(0.8 | )% | (5.1 | )% | |||||
Net interest income |
0.3 | % | 0.9 | % | |||||
Loss from continuing operations before income taxes |
(0.5 | )% | (4.2 | )% | |||||
Income tax benefit |
| | |||||||
Loss from continuing operations |
(0.5 | )% | (4.2 | )% | |||||
Income from discontinued operations, net |
0.4 | % | 5.7 | % | |||||
Net income (loss) |
(0.1 | )% | 1.5 | % | |||||
Continuing Operations:
Revenue for the nine months ended September 30, 2003 was $53.5 million, an increase of $2.8 million or 5.6% compared to revenue of $50.6 million for the prior year nine month period.
Health Management Systems, which provides third party liability identification and recovery services to state Medicaid agencies, generated revenue of $26.8 million in the current year nine month period, a $2.8 million or 11.9% increase over the prior year nine month period revenue of $23.9 million. This increase reflects a $900,000 increase in revenue from a state customer reflecting an expansion in the scope of services provided and an additional $292,000 of revenue from two new state clients. In addition, revenue also increased by $2.5 million reflecting non-recurring revenue opportunities, timing differences, and changes in the volume, yields and scope of client projects. The increase in revenue was partially offset by a $878,000 reduction in revenue from the expiration of a client relationship since the prior year period.
Accordis, which provides outsourced business office services for hospitals, generated revenue of $26.7 million in the current year nine month period, which was consistent with the prior period revenue. While revenue was consistent with the prior period, there were several offsetting revenue increases and decreases as follows. Revenue for the current year nine month period included $2.6 million of revenue from three new customers, and a $3.4 million increase with five customers resulting from an expansion in the scope of services provided. Revenue for the current year nine month period decreased by $3.4 million across the comparable client base reflecting specific non-recurring revenue opportunities with certain clients based on their particular needs, differences in the timing of when client projects were completed in the current year compared with the prior year, and changes in the volume and yields of client projects including an estimated revenue loss in the second quarter of $1.2 million attributable to processing delays and other impacts of the redirection of operational resources to regulatory matters. See Part II-Item 1. Legal Proceedings. There was also a decrease in revenue of $2.5 million associated with 12 terminated or inactive customer relationships.
16
Compensation expense as a percentage of revenue was 54.3% for the nine months ended September 30, 2003 compared to 55.8% for the nine months ended September 30, 2002 and for the current year nine month period was $29.1 million, an increase of $906,000 or 3.2% compared to the prior year nine month period. This increase resulted from an increase in headcount from the comparable prior year period, a general increase in compensation rates and increased costs of fringe benefits. At September 30, 2003, we had 494 employees, compared to 480 employees at September 30, 2002. The current year headcount and related compensation expense reflects a shift to service center employees for the provision of business outsourcing services from higher paid information technology employees engaged in service development initiatives and system enhancement and reconfiguration activities during the prior year.
Data processing expense as a percentage of revenue was 6.7% for the nine months ended September 30, 2003 compared to 9.6% for the nine months ended September 30, 2002 and for the current year nine month period was $3.6 million, a decrease of $1.3 million or 27.1% compared to the prior year period. The prior year costs included costs associated with service development and system enhancement and reconfiguration activities that were terminated in the second quarter of 2002.
Occupancy expense as a percentage of revenue was 7.9% for the nine months ended September 30, 2003 compared to 9.1% for the nine months ended September 30, 2002 and for the current period was $4.2 million, a decrease of $370,000 or 8.0% compared to the prior year period. The reduction in occupancy costs is due to subletting one floor at our New York City headquarters.
In fiscal years 2002 and 2001, direct project costs as a percentage of revenue were approximately 15% to 16%. The Company has experienced quarterly variations of as much as 2% in that percentage range based on the particular mix of client business in the period. In fiscal year 2003 the Company has attempted to more precisely identify as direct project costs, expenses that were previously classified as other operating costs. As a consequence, the Company expects that in fiscal 2003 direct project costs as a percentage of revenue will be approximately 17% to 18%, subject to quarterly variations comparable to past experience.
Direct project costs as a percentage of revenue were 17.9% for the nine months ended September 30, 2003 compared to 14.5% for the nine months ended September 30, 2002 and for the current year nine month period were $9.6 million, an increase of $2.2 million or 30.2% compared to the prior year period. In addition to the discussion above, during the current year nine month period, the increase related to Accordis was principally due to a change in revenue mix between the two periods to engagements with a higher subcontractor and other outside vendor content. The increase related to Health Management Systems was consistent with the increase in revenue.
Other operating costs as a percentage of revenue were 14.0% for the nine months ended September 30, 2003 compared to 16.1% for the nine months ended September 30, 2002 and for the current year nine month period were $7.5 million, a decrease of $710,000 or 8.7% compared to the prior year nine month period. This net decrease results from: (1) a decrease of $1.5 million primarily for consulting and professional service fees associated with a service development initiative and a system reconfiguration effort, both of which were terminated in the second quarter in 2002; (2) $649,000 of expense in the prior year period related to certain stock option grants to members of the Board of Directors; (3) the more strict identification of some expenses as direct project costs, as discussed above; and (4) was partially offset by $2.0 million in expenses primarily for legal fees associated with our response to the subpoena from the United States Attorneys Office.
Total operating expenses as a percentage of revenue were 100.8% for the nine months ended September 30, 2003 compared to 105.1% for the nine months ended September 30, 2002 and for the current year nine month period were $ 53.9 million, an increase of $726,000 or 1.4% compared to the prior year nine month period.
17
Operating loss for the nine months ended September 30, 2003 was $445,000 compared to $2.6 million for the nine months ended September 30, 2002. The Accordis operating loss was $5.0 million for the nine months ended September 30, 2003 compared to an operating loss of $6.4 million in the prior year period. Health Management Systems had an operating profit of $4.5 million for the nine months ended September 30, 2003 compared to an operating profit of $3.8 million for the nine month period ended September 30, 2002. The Accordis operating loss in the current year nine month period includes $2.0 million for legal fees associated with our response to the subpoena from the United States Attorneys Office.
Net interest income of $202,000 for the current year nine month period, compared to $413,000 in the prior year nine month period, reflects a significant decrease in the prevailing market interest rates along with the maturing of certain investments with a higher rate of return which more than offset an increase resulting from the generally greater average balances in cash and short term investments available during the current period.
In the current year, we did not recognize any income tax benefit against our net losses. This absence of an income tax benefit reflects an increase in our valuation allowance for the recovery of our net deferred income tax assets. We have incurred significant taxable losses the last few years and expect to incur a tax loss during fiscal year 2003. Most of our deferred income tax assets are in the form of net operating loss carryforwards. A recoverability analysis was performed based on our recent taxable loss history and projections of future taxable operating results.
Loss from continuing operations was $243,000 in the current year nine month period compared to a loss of $2.2 million during the prior year period. This decrease in operating loss results from increased revenues and the decreases in costs of operations, as discussed above, partially offset by $2.0 million in expenses primarily for legal fees associated with our response to the subpoena from the United States Attorneys Office.
As more fully discussed in Note 6 of the Notes to the Condensed Consolidated Financial Statements, we reported the results of PSG as a discontinued operation for all periods presented. During the prior year nine month period, income from discontinued operations of $2.9 million principally resulted from a termination fee received from a former customer of the PSG, which was not included in the prior disposal estimate. The current year income from discontinued operations is due to the actual operating results of PSG during the wind-down of this business.
Net loss was $31,000 for the first nine months of fiscal year 2003 or $0.00 per common share compared to a net income of $750,000 or $0.04 per common share in the prior year nine month period. The current year results include a loss from continuing operations of $0.01 per common share and income from discontinued operations of $0.01 per common share compared to a loss from continuing operations of $0.12 per common share and income from discontinued operations of $0.16 per common share in the prior year nine month period.
Liquidity and Capital Resources
Historically, our principal sources of funds are operations and the remaining proceeds from our initial public offering in 1992. At September 30, 2003, our cash and short-term investments and net working capital were $24.7 million and $30.6 million, respectively. Although we expect that operating cash flows will be a primary source of liquidity, the current significant cash and short-term investment balances and working capital position are also fundamental sources of liquidity and capital resources. The current cash and short-term investment balances are more than sufficient to meet our short-term funding needs that are not met by operating cash flows. Operating cash flows could be adversely effected by a decrease in demand for our services. Our typical customer relationship, however, usually has a duration of several years, such that we do not expect any current decrease in demand. We estimate that we will purchase approximately $1.5 million of property and equipment during 2003. The payments
18
due by period for our contractual obligations, consisting principally of facility lease obligations and equipment rental and software license obligations, are as follows (in thousands):
Less than | ||||||||||||||||
Total | One Year | 2-3 Years | 4-5 Years | After 5 years | ||||||||||||
$39,194 | $ | 1,503 | $ | 10,641 | $ | 7,770 | $ | 19,280 |
We have entered into sublease arrangements for some of our facility obligations and expect to receive the following rental receipts (in thousands):
Less than | ||||||||||||||||
Total | One Year | 2-3 Years | 4-5 Years | After 5 years | ||||||||||||
$10,624 | $ | 485 | $ | 4,500 | $ | 2,406 | $ | 3,233 |
For the nine month period ended September 30, 2003, cash used in operations was $625,000 compared with cash used in operations of $3.0 million for the prior year period. The current year period use of cash in operations of $625,000 compared to the net loss of $31,000: (a) includes a decrease in accounts payable, accrued expenses and other liabilities of $1.7 million primarily related to the payment of 2002 year-end bonuses and payments against liabilities for previously recognized restructuring charges and (b) includes an increase in accounts receivable of $917,000 reflecting the increase in revenues and (c) was partially offset by depreciation and amortization expense of $2.0 million. During the current year nine month period, cash provided by investing activities was $405,000 reflecting the net proceeds of a matured investment of $1.0 million partially offset by property and equipment purchases of $595,000. Cash provided by financing activities was $454,000 reflecting $48,000 from the issuance of stock under the now inactive employee stock purchase plan, proceeds of $150,000 from the exercise of employee stock options and $361,000 from the final repayment of a note receivable from an officer, which amounts were partially offset by $105,000 used to repurchase our common stock in the open market.
On May 28, 1997, the Board of Directors authorized us to repurchase such number of shares of our common stock that have an aggregate purchase price not in excess of $10,000,000. During the nine months ended September 30, 2003, we purchased 35,800 shares on the open market at a total cost of $105,000. Cumulatively since the inception of the repurchase program, we have repurchased 1,644,916 shares having an aggregate purchase price of $9,289,000.
Item 3. Quantitative and Qualitative Disclosures About Market Risks
Our holdings of financial instruments are comprised of state government debt. All such instruments are classified as securities available for sale. We do not invest in portfolio equity securities or commodities or use financial derivatives for trading purposes. Our debt security portfolio represents funds held temporarily, pending use in our business and operations. We manage these funds accordingly. We seek reasonable assuredness of the safety of principal and market liquidity by investing in rated fixed income securities while, at the same time, seeking to achieve a favorable rate of return. Our market risk exposure consists principally of exposure to changes in interest rates. Our holdings are also exposed to the risks of changes in the credit quality of issuers. We typically invest in the shorter-end of the maturity spectrum of highly liquid investments.
The table below presents the historic cost basis and the fair value for the Companys investment portfolio as of September 30, 2003, and the related weighted average interest rates by year of maturity (in thousands):
19
Matures Year | ||||||||||||
Ending | Total | Total | ||||||||||
December 31, 2003 | Historical Cost | Fair value | ||||||||||
Fixed income governmental securities |
$ | 100 | $ | 100 | $ | 100 | ||||||
Average interest rate |
0.9 | % | 0.9 | % | $ | 100 |
Item 4. Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Securities Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SECs rules and forms, and that such information is accumulated and communicated to our management, including our Chairman and Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As of September 30, 2003, we carried out an evaluation, under the supervision and with the participation of our management, including our Chairman and Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based upon that evaluation, our Chairman and Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective in enabling us to record, process, summarize and report information required to be included in our periodic SEC filings within the required time period.
There have been no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II OTHER INFORMATION
Item 1. Legal Proceedings
(a) | HHL Financial Services | ||
On June 28, 1998, eight holders of promissory notes (the Notes) of HHL Financial Services, Inc. (HHL) commenced a lawsuit against us and others in the Supreme Court of the State of New York, County of Nassau, alleging various breaches of fiduciary duty between 1990 and 1996 against HHL (the first cause of action) and that defendants intentionally caused HHLs default under the Notes (the second cause of action). The complaint alleges that the defendants caused HHL to make substantial unjustified payments to us which, ultimately, led to defaults on the Notes and to HHLs filing for Chapter 11 bankruptcy protection in 1997. The plaintiffs are seeking damages in the amount of $2.3 million (for the unpaid notes) plus interest. As a result of motion practice before the Bankruptcy Court, the breach of fiduciary duty claim was dismissed. A motion to dismiss the remaining cause of action, for tortious interference with contract, was denied by the New York Supreme Court, and an appeal was taken. On March 3, 2003, the Appellate Division Second Department affirmed the lower Courts decision holding that the Complaint pleaded a cognizable cause of action for tortious interference. We have answered the Complaint, and both sides are engaging in discovery. We intend to continue our vigorous defense of this lawsuit. Management believes the risk of loss is not probable and accordingly has not recognized any |
20
accrued liability for this matter. Although the outcome of this matter cannot be predicted with certainty, we believe that any liability that may result will not, in the aggregate, have a material adverse effect on our financial position or cash flows, although it could be material to our operating results in any one accounting period.
(b) Subpoena from the United States Attorneys Office
On January 31, 2003, we announced that we had received a subpoena issued under the Health Insurance Portability and Accountability Act of 1996 from the United States Attorneys Office for the Southern District of New York in connection with an investigation relating to possible federal health care offenses. The subpoena seeks the production of certain documents from January 1982 to present relating to medical reimbursement claims submitted by us to Medicare, Medicaid, and other federal healthcare programs, particularly on behalf of a significant client of Accordis. At this point in the investigation, the United States Attorneys Office has not filed any complaint asserting any violations of law.
The Companys board of directors has appointed a special committee to oversee the Companys response to the investigation. We continue to cooperate fully with the investigation.
We are not able to give any assurances as to the duration or outcome of the investigation or as to the effect that any proceedings that may be brought by the government may have on our financial condition or results of operations. The initiation of proceedings against us, even if we are ultimately successful in defending them, could have a material adverse effect on our business. Since the receipt of the subpoena, our revenue and expense levels have been adversely affected as management undertook to comply with the demands of document production and to review the matters covered by the subpoena. We anticipate that we will continue to incur significant legal expenses while the investigation is still ongoing.
Other legal proceedings to which we are a party, in the opinion of our management, are not expected to have a material adverse effect on our financial position, results of operations, or liquidity.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits
In accordance with SEC Release No. 33-8212, Exhibits 32.1 and 32.2 are to be treated as accompanying this report rather than filed as part of the report. |
31.1 | Certification pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by William F. Miller III, Chairman of the Board of Directors and Chief Executive Officer of HMS Holdings Corp. | |
31.2 | Certification pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Philip Rydzewski, Chief Financial Officer of HMS Holdings Corp. | |
32.1 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by William F. Miller III, Chairman of the Board of Directors and Chief Executive Officer of HMS Holdings Corp. | |
32.2 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Philip Rydzewski, Chief Financial Officer of HMS Holdings Corp. |
21
(b) Reports on Form 8-K
(1) During the third quarter of 2003, we filed a report on Form 8-K dated as of July 29, 2003. | ||
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits | ||
Press release issued by us on July 29, 2003. | ||
Item 12. Results of Operations and Financial Condition |
22
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: November 6, 2003 | HMS HOLDINGS CORP. | ||
|
|||
(Registrant) |
By: | /s/ William F. Miller III | |||
William F. Miller III Chairman and Chief Executive Officer (Principal Executive Officer) |
||||
By: | /s/ Philip Rydzewski | |||
Philip Rydzewski Chief Financial Officer (Principal Financial Officer and Accounting Officer) |
23